Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors

Chemical & Pharmaceutical Bulletin
Rabah Ahmed Taha SeryaDalal Abdelrahman Abou El Ella

Abstract

A novel series of quinzoline based compounds (IIIa-d, VIa-f, IXa-f) were designed, synthesized and screened for their inhibitory activity towards the PDE4B isoform. The in vivo anti-inflammatory effect of the titled compounds (IIIa-d, VIa-f, IXa-f) as well as their effect on the level of tumor necrosis factor (TNF-α) were evaluated. Among all of the synthesized compounds, IXb, IXd and IXf, exhibited good inhibitory activity against PDE4B enzyme with inhibition percentages of 42, 62 and 68%, respectively. Most of the tested compounds showed potent anti-inflammatory activity compared to indomethacin with a marked decrease in TNF-α level. The ulcerogenic effect of the tested compounds was also examined. The gastric mucosa of the tested animals remained intact after oral administration of the hit compounds. Additionally, docking study was used to explore the possible binding mode of the active compounds on the PDE4B enzyme as well as to illustrate the selectivity of the active hits on the PDE4B isoform.

References

Jan 1, 1990·Annual Review of Biochemistry·K I AraiT Yokota
May 1, 1991·Journal of Periodontal Research·P T MaruchaD L Kreutzer
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J R GambleM A Vadas
Apr 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·A RobertJ E Nezamis
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·J L GouletB H Koller
Nov 1, 1994·Journal of Leukocyte Biology·A HaradaK Matsushima
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·S H SoderlingJ A Beavo
Jun 1, 2002·Bioorganic & Medicinal Chemistry Letters·Motasim BillahJulie B H Warneck
Jun 1, 2002·Bioorganic & Medicinal Chemistry Letters·Motasim BillahJulie B H Warneck
Dec 21, 2002·The Journal of Biological Chemistry·Marco ContiCatherine Jin
Dec 1, 1962·Proceedings of the Society for Experimental Biology and Medicine·C A WINTERG W NUSS
Feb 26, 2004·Bioorganic & Medicinal Chemistry·Carine Deleuze-MasquéfaPierre-Antoine Bonnet
Jul 21, 2004·Molecular Cell·Kam Y J ZhangGideon Bollag
Sep 8, 2004·Bioorganic & Medicinal Chemistry·Hiroshi OchiaiMasaaki Toda
Dec 4, 2004·Structure·Graeme L CardKam Y J Zhang
Jan 13, 2006·British Journal of Pharmacology·Victoria Boswell-SmithClive P Page
Apr 28, 2007·American Journal of Respiratory and Critical Care Medicine·Peter M A CalverleyLeonardo M Fabbri
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
Mar 1, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C HerbertR K Kumar
May 2, 2008·Expert Opinion on Investigational Drugs·Stephen K Field
Jun 10, 2008·Bioorganic & Medicinal Chemistry Letters·J Nicole HamblinJoanne O Wiseman
May 26, 2009·Bioorganic & Medicinal Chemistry Letters·Amanda P SkoumbourdisCraig J Thomas
Aug 7, 2009·Bioorganic & Medicinal Chemistry Letters·Michael D WoodrowJoanne O Wiseman
Jan 5, 2011·European Journal of Medicinal Chemistry·Sahar Mahmoud Abou-SeriDalal A Abou El Ella
Jun 9, 2011·British Journal of Pharmacology·O BrunoR Ricciarelli

❮ Previous
Next ❯

Citations

Jul 28, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dorota G PiotrowskaMagdalena Grabkowska-Drużyc

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.